EPA-Approved SARS-CoV-2 Disinfectants
7 rows where Formulation_type contains "Electrostatic Spray" and Why_on_List_N = "Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim"
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Active_ingredient,
Why_on_List_N
✖
- Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim · 7 ✖
ID ▼
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type
|
Contact_time
|
Formulation_type
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
1438 |
6836-277 |
Increased Risk |
Quaternary ammonium |
BARDAC 205M-1.30 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
10.0 minutes |
Dilutable; Electrostatic Spray |
Norovirus |
2020-03-13 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1439 |
6836-303 |
Increased Risk |
Quaternary ammonium |
BARDAC 205M-5.2 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
10.0 minutes |
Dilutable; Electrostatic Spray |
Norovirus |
2020-03-13 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1478 |
6836-266 |
Increased Risk |
Quaternary ammonium |
BARDAC 205M-10 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
10.0 minutes |
Dilutable; Electrostatic Spray |
Norovirus |
2020-03-03 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1479 |
6836-278 |
Increased Risk |
Quaternary ammonium |
BARDAC 205M- 14.08 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
10.0 minutes |
Dilutable; Electrostatic Spray |
Norovirus |
2020-03-03 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1480 |
6836-289 |
Increased Risk |
Quaternary ammonium |
BARDAC 205M RTU |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
10.0 minutes |
Ready-to-use; Electrostatic Spray |
Norovirus |
2020-03-03 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1481 |
6836-302 |
Increased Risk |
Quaternary ammonium |
BARDAC 205M-2.6 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) |
10.0 minutes |
Dilutable; Electrostatic Spray |
Norovirus |
2020-03-03 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1486 |
6836-70 |
Increased Risk |
Quaternary ammonium |
BARDAC 205M-7.5 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
10.0 minutes |
Dilutable; Electrostatic Spray |
Norovirus |
2020-03-03 |
Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |